Weight loss drugs like Ozempic and Wegovy have gained popularity for their ability to help users shed pounds, but medical ...

We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...

Critics, including Senator Bernie Sanders, question whether the push to block alternatives is truly about safety — or simply ...

Shirleyann Metcalfe, 64, told i she was almost instantly approved for online pharmacist Voy’s GLP1 weight-loss programme – ...

One the bigger drivers of Medicaid’s rising costs is the ballooning expense of covering weight loss drugs, a state Senate ...

America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...

America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-los ...

Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish drugmaker's next-generation experimental obesity drug CagriSema, a source ...

According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, ...

More than half of U.S. adults now qualify to take semaglutide, the popular diabetes and weight loss drug sold under the brand names Ozempic and Wegovy.

For years, Miriam Schulman of Highland Park, New Jersey, struggled with what she called ‘food noise.’ “You’re always thinking ...